VKTX
Viking Therapeutics, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +2.6% · posisi baru bersih 0.0% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 24.17K | $674,494 | n/a | −1 |
| Q2 2026 | 108 | +6 | 57.61M | $2.25B | +9 | −4 |
| Q1 2026 | 106 | -1 | 56.45M | $1.88B | +7 | −8 |
| Q4 2025 | 106 | +1 | 58.95M | $2.07B | +2 | −1 |
| Q3 2025 | 16 | -1 | 41.62M | $1.09B | +2 | −4 |
| Q2 2025 | 15 | 0 | 36.99M | $980.19M | +2 | −2 |
| Q1 2025 | 12 | +3 | 10.64M | $256.98M | +3 | n/a |
| Q4 2024 | 9 | -3 | 10.39M | $418.15M | n/a | −3 |
| Q3 2024 | 11 | -1 | 6.74M | $426.33M | n/a | −1 |
| Q2 2024 | 12 | n/a | 5.57M | $295.04M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 10.16M | n/a | $269.31M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | Fidelity (FMR) ✦ | 9.82M | n/a | $260.28M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | BlackRock ✦ (pasif) | 5.44M | n/a | $144.09M | 0.0% | n/c | 1 | SEC ↗ ×19 |
| 4 | State Street Global Advisors ✦ (pasif) | 3.78M | -6.9% | $100.06M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasif) | 1.92M | -3.1% | $50.98M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Norges Bank ✦ (pasif) | 1.77M | +14.4% | $46.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 1.31M | +2406.6% | $34.82M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | Millennium Management ✦ | 941.94K | +272.8% | $24.96M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 872.98K | -47.1% | $23.13M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Duquesne Family Office ✦ | 549.29K | Baru | $14.56M | 0.4% | New | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 205.47K | -37.0% | $5.45M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 12 | T. Rowe Price ✦ | 78.18K | +11.5% | $2.07M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 64.73K | -55.4% | $1.72M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 14 | Point72 Asset Management ✦ | 39.93K | Baru | $1.06M | 0.0% | New | 1 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 32.70K | -90.0% | $866,550 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Duquesne Family Office | $14.56M | 0.4% |
| Point72 Asset Management | $1.06M | 0.0% |
Telah keluar
| Marshall Wace | $5.02M | adalah 0.0% |
| Gotham Asset Management | $591,675 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 9.80K saham, $318 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.